-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PM-534 in Castration-Resistant Prostate Cancer (CRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PM-534 in Castration-Resistant Prostate Cancer (CRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PM-534 in Castration-Resistant Prostate Cancer (CRPC) Drug Details: PM-534 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VT-1021 in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VT-1021 in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VT-1021 in Pancreatic Ductal Adenocarcinoma Drug Details: VT-1021 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VT-1021 in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VT-1021 in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VT-1021 in Recurrent Glioblastoma Multiforme (GBM) Drug Details: VT-1021...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Favezelimab in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Favezelimab in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Favezelimab in Diffuse Large B-Cell Lymphoma Drug Details: Favezelimab (MK-4280)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ONCT-808 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ONCT-808 in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ONCT-808 in Mantle Cell Lymphoma Drug Details: ONCT-808 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BT-8009 in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BT-8009 in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BT-8009 in Epithelial Ovarian Cancer Drug Details: BT-8009 is under...
-
Product Insights
NewElectrophysiology Ablation Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Electrophysiology Ablation Catheters Pipeline Market Report Overview Electrophysiology ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence. The electrophysiology ablation catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and...
-
Product Insights
Electrophysiology Diagnostic Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Electrophysiology Diagnostic Catheters Pipeline Market Report Overview Electrophysiology Diagnostic Catheters are used for temporary intracardiac sensing, recording, stimulation, and mapping. These catheters include a tube with an electrode at its end that is threaded through an artery into the heart to record electrical activity. It can also emit electrical impulses and detect the heart’s response. Steerable Diagnostic Catheters is the only segment in the Electrophysiology Diagnostic Catheters pipeline market. The Electrophysiology Diagnostic Catheters pipeline market research report provides a comprehensive...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Gastric Cancer Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Oteseconazole in Cryptococcal Meningitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Oteseconazole in Cryptococcal Meningitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Oteseconazole in Cryptococcal Meningitis Drug Details: Oteseconazole (Vivjoa) is a potent and...